• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Novitropan
    / CTS


    Active Ingredient
    Oxybutynin (HCl) 5 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    30 X 5 mg

    full basket chart 56320 14083

    Tablets

    100 X 5 mg

    full basket chart 1531 14178

    Related information


    Dosage

    Adults: One tablet 2-3 times per day. Maximum dosage per day is 4 tablets.
    Children over 5 years of age: One tablet twice a day. Maximum dosage per day is 3 tablets.
    If Novitropan is intended for treating bed-wetting, take the last dose at bedtime.
    See prescribing information for full details.


    recommended drugs

    Indications

    Uninhibited neurogenic and reflex neurogenic bladder, eneuresis.


    Contra-Indications

    Hypersensitivity to the drug. Glaucoma, partial or complete obstruction of gastrointestinal tract, paralytic ileus, intestinal atony of elderly or debilitated patients, megacolon, toxic megacolon complicating ulcerative colitis, severe colitis and myasthenia gravis, obstructive uropathy, unstable cardiovascular status in acute hemorrhage.


    Special Precautions

    High environmental temperature, can cause heat prostration. Pregnancy and lactation, children under 5 years of age, the elderly, all patients with autonomic neuropathy, hepatic or renal disease. The symptoms of hyperthyroidism, coronary heart disease, congestive heart failure, cardiac arrhythmias, tachycardia, hypertension and prostatic hypertrophy may be aggravated following administration. Hiatal hernia associated with reflux esophagitis. Pre-treatment examination should include cystometry and other appropriate measures. Driving a vehicle or operating machinery.


    Side Effects

    Dry mouth, decreased sweating, urinary hesitancy and retention, blurred vision, tachycardia, palpitations, dilatation of the pupil, cycloplegia, increased ocular tension, drowsiness, weakness, dizziness, insomnia, nausea, vomiting, constipation, bloated feeling, impotence, suppression of lactation, severe allergic reactions or drug idiosyncrasies, including urticaria and other dermal manifestations.


    Drug interactions

    Anticholinergics.


    Manufacturer
    CTS Chemical Industries Ltd
    CLOSE